Cart
sales@molnova.com
Caspase 1 Substrate 2m (ICE), fluorogenic
CAS No. 149231-65-2
Caspase 1 Substrate 2m (ICE), fluorogenic( ——— )
Catalog No. M41685 CAS No. 149231-65-2
Ac-YVAD-AMC is an inhibitor for caspase. Ac-YVAD-AMC inhibits bacteria-induced cell death of hypersensitive response (HR) cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCaspase 1 Substrate 2m (ICE), fluorogenic
-
NoteResearch use only, not for human use.
-
Brief DescriptionAc-YVAD-AMC is an inhibitor for caspase. Ac-YVAD-AMC inhibits bacteria-induced cell death of hypersensitive response (HR) cells.
-
DescriptionAc-YVAD-AMC is an inhibitor for caspase. Ac-YVAD-AMC inhibits bacteria-induced cell death of hypersensitive response (HR) cells.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number149231-65-2
-
Formula Weight665.7
-
Molecular FormulaC33H39N5O10
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. del Pozo O, et al., Caspases and programmed cell death in the hypersensitive response of plants to pathogens. Curr Biol. 1998 Oct 8;8(20):1129-32.?
molnova catalog
related products
-
GSK-1520489A
GSK-1520489A is an active PKMYT1 inhibitor.
-
Morpholinylmercaptob...
Morpholinylmercaptobenzothiazole is an aftereffect rapid vulcanization accelerator.
-
Kurarinone
Kurarinone, a flavanoid derived from shrub Sophora flavescens,Kurarinone exhibits anti-tumor, estrogenic, and anti-inflammatory activities, it also shows strong inhibitory effect on immune responses.?Kurarinone may ameliorate chronic inflammatory skin diseases through the suppression of pathogenic CD4(+) T-cell differentiation and the overall immune response.
